Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
International Journal of Clinical and Experimental Pathology|January 14, 2011
Enhanced expression of CD74 in gastrointestinal cancers and benign tissuesDavid V Gold, Rhona Stein, Jack Burton, et al.
Molecular Cancer|November 22, 2013
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucinDavid V Gold, Guy Newsome, Donglin Liu, et al.
Oncotarget|January 18, 2015
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancerDonglin Liu, Chien-Hsing Chang, David V Gold, et al.
Archives of Pathology & Laboratory Medicine|January 31, 2014
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistryChanjuan Shi, Nipun Merchant, Guy Newsome, et al.
Methods in Molecular Medicine|May 25, 2005
Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapyDavid E Modrak
Human Immunology|April 17, 2012
Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic miceAlice P Taylor, Boby Makabi-Panzu, Xiaochuan Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2012
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumabXiaochuan Chen, Chien-Hsing Chang, Rhona Stein, et al.
Plos One|February 14, 2013
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathologyDavid M Goldenberg, David V Gold, Meiyu Loo, et al.
Molecular Cancer Therapeutics|February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancersSerengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
CD74 is expressed by multiple myeloma and is a promising target for therapyJack D Burton, Scott Ely, Praveen K Reddy, et al.
Pageof 31